LEGAL ACTION UPDATE:
On April 1, 2020, the FDA requested an immediate recall of all ranitidine (Zantac) products from the market. Zantac is linked to an increased risk of cancer.
Ranitidine, known under the brand name of Zantac, is a heartburn medication that, for years, was sold both over the counter and as a prescription. GSK developed Zantac in 1977 and was approved by the FDA in 1983. In 2004, Pfizer developed an over-the-counter version, then sold it to Boehringer Ingelheim in 2006. Later, Sanofi-AS purchased OTC Zantac in 2017. To date, there are more than 20 different generic manufacturers of ranitidine. However, recent studies have shown Zantac may contain unsafe amounts of the carcinogen NDMA, a known probable carcinogen.
If you or your loved one was diagnosed with cancer after taking Zantac, we may be able to help. Call (888) 783-8378 for your free case evaluation.
What is NDMA?
NDMA stands for Ni-nitrosodimethylamine. NDMA is classified as a probable human carcinogen, which is a substance that causes cancer. It is not only usd to manufacture rocket fuel, but it is also used to induce tumors in animals for laboratory experiments. The FDA’s daily allowable limit is 96ng.
On September 13, 2019, FDA issued a statement that some ranitidine products contain NDMA at low levels. On October 2, 2019, the FDA disclosed that they found “unacceptable levels of NDMA” in samples of ranitidine. This statement prompted voluntary recalls across the world. Additionally, Canada asked companies to stop distributing Zantac and France recalled all ranitidine products.
What is the problem with Zantac antacid?
Valisure LLC and ValisureRX LLC conducted tests, finding very high levels of NDMA in all lots of ranitidine tested. Valisure tests showed the NDMA concentration in a patient’s urine to be more than 15,000 times higher than the California drinking water limit. A Stanford study studied NDMA levels in patients 24 before taking ranitidine and 24 hours. They found the NDMA levels in urine increased by 430 times, averaging 47,600 ng per person. That is 495 times higher than the FDA daily limit of NDMA. Scientists have also tested other heartburn medications such as Prilosec, Nexium, Prevacid, and Pepcid. They did not contain levels of NDMA. However, they have been linked to kidney disease, renal failure, and other kidney damage.
FAQs about Zantac Heartburn Medication
Should I stop taking Zantac?
Zantac has been completely recalled, so you are no longer able to purchase it at the store. Doctors will no longer prescribe Zantac. Talk to your doctor before discontinuing use of any medication, and speak to him or her about any alternatives that may be available to you.
What is the cancer causing ingredient in Zantac?
As mentioned above, some raniditine products like Zantac may contain NDMA. NDMA is a probable human carcinogen.
How long must someone take Zantac before it could cause cancer?
Researchers continue to conduct studies on ranitidine and its likelihood of causing cancer. We are currently accepting cases where clients have used Zantac/ranitidine products anywhere from just a few months to several decades.
Which cancers does Zantac cause?
Zantac may cause the following cancers. This is a non-exhaustive list.
The Ruth Law Team is actively filing complaints with the following diagnosed cancers:
- Bladder Cancer
- Esophageal Cancer
- Gastric or Stomach Cancer
- Liver Cancer
- Pancreatic Cancer
Update Multi-District Litigation, November 19, 2021:
Breast cancer and kidney cancer were excluded from the cancer’s being litigated in the multi-district proceedings in the United States Southern District of Florida.
If you are looking for an experienced attorney to handle your or your loved one’s Zantac case, we’d like to partner with you. Contact the product liability attorneys at The Ruth Law Team at (888) 783-8378. We have decades of experience going up against big corporations. We fight for our clients’ rights and are here for you. The Ruth Law Team also handles wrongful death claims related to Zantac. Our phone lines are open 24/7, or you may contact us using the web form on this page.